Medical Information
Saudi Arabia
 

This medical Information website is intended only for Healthcare Professionals in the Kingdom of Saudi Arabia. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

This content is intended for Healthcare professionals in Saudi Arabia. Would you like to proceed?

I am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
SelectI am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
I am not a healthcare professionalNo, go back to the patient portal
SelectI am not a healthcare professionalNo, go back to the patient portal
Non-Saudi Arabia residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Williams JH, Reddy M, Zhang Y, Del Frari L, Matschke K, Litwiler K March 18, 2022 ASCPT 2022 Skin Cancer

Effect of Encorafenib in Combination With Binimetinib on Substrates for OATP1B1/3, BCRP, and CYP2B6 in Patients With BRAF V600-Mutant Unresectable or Metastatic Melanoma or Other Advanced Solid Tumors

View Presentation
Poster
Dummer R, Pathan N, Zhu Z, Robert C, Arance A, de Groot JWB, Garbe C, Gogas HJ, Gutzmer R, Krajsova I, Liszkay G, Loquai C, Mandala M, Schadendorf D, Yamazaki N, Edwards M, Cantey-Kiser J, di Pietro A, Deng S, Ascierto PA, Flaherty K April 12, 2022 AACR 2022 Skin Cancer

Molecular Correlates of Clinical Benefit From Circulating Tumor DNA (ctDNA): Analysis of the COLUMBUS Study

View Presentation
Oral Presentation
Dummer R, Pathan N, Deng S, Robert C, Arance A, de Groot JWB, Garbe C, Gogas HJ, Gutzmer R, Krajsova I, Liszkay G, Loquai C, Mandala M, Schadendorf D, Yamazaki N, di Pietro A, Xie T, Ascierto PA, Flaherty K September 12, 2022 ESMO 2022 Skin Cancer

Tumor Biomarker Analysis From COLUMBUS Part 1: Encorafenib + Binimetinib for BRAF V600E/K-Mutant Advanced or Metastatic Melanoma

View Presentation View Abstract Plain Language Summary